Table 5 Study population and sample size (BRAC)
From: Rising pharmaceutical innovation in the Global South: a landscape study
Categories | Key informants participated | Numbers of KIIs |
|---|---|---|
Implementors | Head of Research/Research Unit Directors, Quality control/assurance officers | 6 |
Financers | MD/CEO of the pharmaceuticals with R&D or Product Development | 4 |
Facilitators | DGDA, academics/faculties/researchers (pharmacy & pharmacology) of different universities and research organizations | 8 |